Do methotrexate-albumin and aminopterin-albumin effectively prevent experimental acute graft-versus-host disease?
The albumin conjugates MTX-HSA and AMPT-HSA effectively prevent experimental aGVHD.
The intention to discharge patients on the day of surgery, with planned postoperative review at 2 weeks, was associated with a low frequency of serious ocular complications. Differences in the proportions achieving a good visual outcome between the two groups, based on 2 week visual acuity and 4 month quality of life, were not significant.